SNCA and Parkinson disease: Similarly, in the PD model, patient hiPSC-derived midbrain organoids with genetic mutations of SNCA-A53T and LRRK2-G2019S exhibited dopaminergic neuronal loss and synaptic defects, faithfully recapitulating the pathological hallmarks and gene expression profiles seen in patients [63,64,65].